1. Most Discussed
  2. Gainers & Losers
PAB 3.6¢

A few things to consider...................

  1. hectort

    27 Posts.

    Although not a holder of PAB, I have followed the stock for a long time. Just a few observations and points to ponder.........

    (1) At the last AGM (end 2014), WHY did the shareholders not make sure that the Chairman was voted off the Board? The voting was close (but then the largest shareholder sits on the Board and was eligible to vote!)..............this Board needs to be spilled. They were useless before even when the Company had a CEO but now without a real CEO, they are even worse and clearly don't have a clue.

    (2) The senior management is definately under-qualified. How many Companies out there are running cancer clinical trials without a CMO or a CEO that has some medical background? One thing saying the clinicians in Germany are intending to run the trial but the trial is, ultimately, Patrys' responsibility and they don't have the in-house expertise.

    (3) Why is there not someone senior and qualified sitting in Europe running operations and coordinating the German clinical site? There is no way, surely,that this can be done efficiently from Australia. Where are the decisions being made??

    (4) Manufacturing of complex antibodies obviously requires a lot of coordination within the Company and communication amongst those in Germany, those in the USA (where SM6 is being made) and those in Australia who think they are in charge. Question is.....................what are relations like between these various parties? With no real CEO on board, who is making the critical decisions about the manufacturing?????

    Such a pity on this one...great potential, great science and very promising past clinical data with SM6. Now they have no leadership from either the CEO or the Board. Many of you critisiced the previous CEO but she got SM6 produced on time, she got the MM clinical trial started and finished on time (and the data was good!) and had the other programs moving along well. Not to mention getting Amgen involved with the Company.

    If I had shares, I would be selling out fast.

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.